Minocycline inhibition of monocyte activation correlates with neuronal protection in SIV NeuroAIDS

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Campbell, Jennifer H ^a   Burdo, Tricia H ^a   Autissier, Patrick ^a   Bombardier, Jeffrey P ^b   Westmoreland, Susan V ^b   Soulas, Caroline ^a   González, R Gilberto ^b,c   Ratai, Eva Maria ^b,c   Williams, Kenneth C ^a  

^a BOSTON COLLEGE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; CD16 ANTIGEN; CD163 ANTIGEN; CD64 ANTIGEN; CHEMOKINE RECEPTOR CCR2; HLA DR ANTIGEN; MINOCYCLINE; FC RECEPTOR; INTERLEUKIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL MIGRATION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; IN VITRO STUDY; MACACA; MONOCYTE; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION; ANIMAL; CD8+ T LYMPHOCYTE; CELL COUNT; CELL PROLIFERATION; IMMUNOLOGY; LYMPH NODE; MACACA MULATTA; METABOLISM; NERVE CELL; PATHOLOGY; PHYSIOLOGY; STATISTICAL MODEL; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; ANTIGENS, CD14; CD8-POSITIVE T-LYMPHOCYTES; CELL COUNT; CELL PROLIFERATION; CYTOPROTECTION; INTERLEUKIN-6; LINEAR MODELS; LYMPH NODES; MACACA MULATTA; MINOCYCLINE; MONOCYTES; NEURONS; RECEPTORS, IGG; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS REPLICATION;

EID: 79953742214     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018688     Document Type: Article

References (55)

1. McArthur JC, McDermott MP, McClernon D, St Hillaire C, Conant K, et al. (2004) Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol 61: 1687-1696.
2. McArthur JC, Haughey N, Gartner S, Conant K, Pardo C, et al. (2003) Human immunodeficiency virus-associated dementia: an evolving disease. J Neurovirol 9: 205-221.
3. Gartner S, (2000) HIV infection and dementia. Science 287: 602-604.
4. Persidsky Y, Zheng J, Miller D, Gendelman HE, (2000) Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68: 413-422.
5. Kim WK, Corey S, Alvarez X, Williams K, (2003) Monocyte/macrophage traffic in HIV and SIV encephalitis. J Leukoc Biol 74: 650-656.
6. Kim WK, Avarez X, Williams K, (2005) The role of monocytes and perivascular macrophages in HIV and SIV neuropathogenesis: information from non-human primate models. Neurotox Res 8: 107-115.
7. Hickey WF, Kimura H, (1988) Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239: 290-292.
8. Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, et al. (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107: 828-836.
9. Ziegler-Heitbrock HW, Passlick B, Flieger D, (1988) The monoclonal antimonocyte antibody My4 stains B lymphocytes and two distinct monocyte subsets in human peripheral blood. Hybridoma 7: 521-527.
10. Kim WK, Sun Y, Do H, Autissier P, Halpern EF, et al. (2010) Monocyte heterogeneity underlying phenotypic changes in monocytes according to SIV disease stage. J Leukoc Biol 87: 557-567.
11. Lassmann H, Schmied M, Vass K, Hickey WF, (1993) Bone marrow derived elements and resident microglia in brain inflammation. Glia 7: 19-24.
12. Rappaport J, Joseph J, Croul S, Alexander G, Del Valle L, et al. (1999) Molecular pathway involved in HIV-1-induced CNS pathology: role of viral regulatory protein, Tat. J Leukoc Biol 65: 458-465.
13. Ancuta P, Rao R, Moses A, Mehle A, Shaw SK, et al. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197: 1701-1707.
14. Pulliam L, Gascon R, Stubblebine M, McGuire D, McGrath MS, (1997) Unique monocyte subset in patients with AIDS dementia. Lancet 349: 692-695.
15. Ancuta P, Kunstman KJ, Autissier P, Zaman T, Stone D, et al. (2006) CD16+ monocytes exposed to HIV promote highly efficient viral replication upon differentiation into macrophages and interaction with T cells. Virology 344: 267-276.
16. Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, et al. (2005) Circulating proviral HIV DNA and HIV-associated dementia. AIDS 19: 45-52.
17. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, et al. (2007) The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol 178: 6581-6589.
18. Soulas C, Donahue RE, Dunbar CE, Persons DA, Alvarez X, et al. (2009) Genetically modified CD34+ hematopoietic stem cells contribute to turnover of brain perivascular macrophages in long-term repopulated primates. Am J Pathol 174: 1808-1817.
19. Fischer-Smith T, Croul S, Sverstiuk AE, Capini C, L'Heureux D, et al. (2001) CNS invasion by CD14+/CD16+ peripheral blood-derived monocytes in HIV dementia: perivascular accumulation and reservoir of HIV infection. J Neurovirol 7: 528-541.
20. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, et al. (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193: 905-915.
21. Fischer-Smith T, Bell C, Croul S, Lewis M, Rappaport J, (2008) Monocyte/macrophage trafficking in acquired immunodeficiency syndrome encephalitis: lessons from human and nonhuman primate studies. J Neurovirol 14: 318-326.
22. Aronson AL, (1980) Pharmacotherapeutics of the newer tetracyclines. J Am Vet Med Assoc 176: 1061-1068.
23. Yong VW, Wells J, Giuliani F, Casha S, Power C, et al. (2004) The promise of minocycline in neurology. Lancet Neurol 3: 744-751.
24. Kim HS, Suh YH, (2009) Minocycline and neurodegenerative diseases. Behav Brain Res 196: 168-179.
25. Nikodemova M, Watters JJ, Jackson SJ, Yang SK, Duncan ID, (2007) Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII. J Biol Chem 282: 15208-15216.
26. Shan S, Hong-Min T, Yi F, Jun-Peng G, Yue F, et al. (2009) NEW evidences for fractalkine/CX3CL1 involved in substantia nigral microglial activation and behavioral changes in a rat model of Parkinson's disease. Neurobiol Aging.
27. Zhao C, Ling Z, Newman MB, Bhatia A, Carvey PM, (2007) TNF-alpha knockout and minocycline treatment attenuates blood-brain barrier leakage in MPTP-treated mice. Neurobiol Dis 26: 36-46.
28. Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, et al. (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293: 2003-2011.
29. Tikka T, Fiebich BL, Goldsteins G, Keinanen R, Koistinaho J, (2001) Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia. J Neurosci 21: 2580-2588.
30. Si Q, Cosenza M, Kim MO, Zhao ML, Brownlee M, et al. (2004) A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol 10: 284-292.
31. Schmitz JE, Simon MA, Kuroda MJ, Lifton MA, Ollert MW, et al. (1999) A nonhuman primate model for the selective elimination of CD8+ lymphocytes using a mouse-human chimeric monoclonal antibody. Am J Pathol 154: 1923-1932.
32. Ratai EM, Bombardier JP, Joo CG, Annamalai L, Burdo TH, et al. (2010) Proton magnetic resonance spectroscopy reveals neuroprotection by oral minocycline in a nonhuman primate model of accelerated NeuroAIDS. PLoS One 5: e10523.
33. Williams K, Westmoreland S, Greco J, Ratai E, Lentz M, et al. (2005) Magnetic resonance spectroscopy reveals that activated monocytes contribute to neuronal injury in SIV neuroAIDS. J Clin Invest 115: 2534-2545.
34. Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, et al. (2010) Increased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasma. PLoS Pathog 6: e1000842.
35. Sakellari D, Goodson JM, Kolokotronis A, Konstantinidis A, (2000) Concentration of 3 tetracyclines in plasma, gingival crevice fluid and saliva. J Clin Periodontol 27: 53-60.
36. Clay CC, Rodrigues DS, Ho YS, Fallert BA, Janatpour K, et al. (2007) Neuroinvasion of fluorescein-positive monocytes in acute simian immunodeficiency virus infection. J Virol 81: 12040-12048.
37. Clements JE, Mankowski JL, Gama L, Zink MC, (2008) The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment. J Neurovirol 14: 309-317.
38. Ziegler-Heitbrock L, (2007) The CD14+CD16+ blood monocytes: their role in infection and inflammation. J Leukoc Biol 81: 584-592.
39. Brogden RN, Speight TM, Avery GS, (1975) Minocycline: A review of its antibacterial and pharmacokinetic properties and therapeutic use. Drugs 9: 251-291.
40. Ancuta P, Kamat A, Kunstman KJ, Kim EY, Autissier P, et al. (2008) Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. PLoS One 3: e2516.
41. Chen-Roetling J, Chen L, Regan RF, (2009) Minocycline attenuates iron neurotoxicity in cortical cell cultures. Biochem Biophys Res Commun 386: 322-326.
42. Szeto GL, Brice AK, Yang HC, Barber SA, Siliciano RF, et al. (2010) Minocycline attenuates HIV infection and reactivation by suppressing cellular activation in human CD4+ T cells. J Infect Dis 201: 1132-1140.
43. Saivin S, Houin G, (1988) Clinical pharmacokinetics of doxycycline and minocycline. Clin Pharmacokinet 15: 355-366.
44. Triques K, Stevenson M, (2004) Characterization of restrictions to human immunodeficiency virus type 1 infection of monocytes. J Virol 78: 5523-5527.
45. Peng G, Greenwell-Wild T, Nares S, Jin W, Lei KJ, et al. (2007) Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression. Blood 110: 393-400.
46. Dong C, Kwas C, Wu L, (2009) Transcriptional restriction of human immunodeficiency virus type 1 gene expression in undifferentiated primary monocytes. J Virol 83: 3518-3527.
47. Kriz J, Nguyen MD, Julien JP, (2002) Minocycline slows disease progression in a mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 10: 268-278.
48. Van Den Bosch L, Tilkin P, Lemmens G, Robberecht W, (2002) Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13: 1067-1070.
49. Zhu S, Stavrovskaya IG, Drozda M, Kim BY, Ona V, et al. (2002) Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417: 74-78.
50. Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, et al. (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6: 1045-1053.
51. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
52. Lifson JD, Rossio JL, Piatak M Jr, Parks T, Li L, et al. (2001) Role of CD8(+) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J Virol 75: 10187-10199.
53. Otani I, Mori K, Sata T, Terao K, Doi K, et al. (1999) Accumulation of MAC387+ macrophages in paracortical areas of lymph nodes in rhesus monkeys acutely infected with simian immunodeficiency virus. Microbes Infect 1: 977-985.
54. Bruck W, Porada P, Poser S, Rieckmann P, Hanefeld F, et al. (1995) Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 38: 788-796.
55. Ringler DJ, Wyand MS, Walsh DG, MacKey JJ, Chalifoux LV, et al. (1989) Cellular localization of simian immunodeficiency virus in lymphoid tissues. I. Immunohistochemistry and electron microscopy. Am J Pathol 134: 373-383.